|
Market Closed -
Nasdaq
21:00:00 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 515.02 USD | -1.08% |
|
-4.38% | +13.60% |
| Market Cap | 131B 119B 110B 99.68B 187B 12,091B 197B 1,334B 530B 6,604B 490B 480B 20,727B | P/E 2026 * |
35.9x | P/E 2027 * | 29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 128B 116B 107B 97.58B 183B 11,836B 192B 1,306B 519B 6,465B 480B 469B 20,289B | EV / Sales 2026 * |
9.64x | EV / Sales 2027 * | 8.35x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
| VRTX | Real-time | ||
| VX1 | Real-time | ||
| VX1 | Real-time | ||
| VRTX * | End-of-day quote | ||
| VX1 | Delayed | ||
| VX1 | Delayed | ||
| VX1 | Delayed | ||
| 1VRTX | End-of-day quote | ||
| 0QZU | Delayed | ||
| VRTX | End-of-day quote | ||
| 0QZU | Real-time | ||
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -1.08% | ||
| 1 week | -4.38% | ||
| Current month | -7.85% | ||
| 1 month | -1.81% | ||
| 3 months | -6.03% | ||
| 6 months | +18.79% | ||
| Current year | +13.60% |
| 1 week | 513.8 | 549.56 | |
| 1 month | 509.2 | 568.67 | |
| Current year | 412.27 | 568.67 | |
| 1 year | 412.27 | 568.67 | |
| 3 years | 346.28 | 568.67 | |
| 5 years | 179.96 | 568.67 | |
| 10 years | 71.46 | 568.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Agam Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/10/26 | Free | Director | 795 | 0.0003% | ||
| 15/10/26 | Free | Director | 29 | 0.0000% | ||
| 15/10/26 | Free | Director | 93 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.08% | -4.38% | +20.68% | +45.17% | 131B | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +0.19% | -4.72% | +24.58% | +72.60% | 420B | |
| Weighted average by Cap. | +0.26% | -5.17% | +25.86% | +86.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26B 12.07B 11.13B 10.12B 18.99B 1,228B 19.95B 135B 53.82B 671B 49.74B 48.69B 2,104B | 14.65B 13.35B 12.3B 11.19B 20.99B 1,357B 22.06B 150B 59.49B 741B 54.98B 53.82B 2,326B |
| Net income | 3.66B 3.33B 3.07B 2.79B 5.24B 339B 5.51B 37.37B 14.85B 185B 13.73B 13.44B 581B | 4.52B 4.12B 3.79B 3.45B 6.47B 418B 6.8B 46.15B 18.34B 229B 16.95B 16.6B 717B |
| Net Debt | -2.76B -2.51B -2.32B -2.11B -3.95B -255B -4.15B -28.18B -11.2B -140B -10.35B -10.13B -438B | -8.16B -7.43B -6.85B -6.23B -11.69B -756B -12.29B -83.37B -33.14B -413B -30.62B -29.98B -1,296B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | US$515.02 | -1.08% | 1,767,923 |
| 19/11/26 | US$520.66 | -2.94% | 1,177,432 |
| 18/11/26 | US$536.45 | +0.42% | 1,292,403 |
| 17/11/26 | US$534.20 | -0.67% | 1,512,600 |
| 16/11/26 | US$537.79 | -0.15% | 1,224,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
















